Pacific Biosciences Of California (PACB) Other Operating Expenses (2015 - 2026)

Pacific Biosciences Of California has reported Other Operating Expenses for 8 years, with the latest figure at $45.8 million in Q1 2026.

• On a quarterly basis, Other Operating Expenses changed N/A year-over-year to $45.8 million in Q1 2026; TTM through Jun 2026 was $42.3 million, a 53.94% decrease from a year earlier, with the FY2025 full-year figure at $347.8 million, up 85.16% from the prior year.
• Other Operating Expenses was $45.8 million for Q1 2026 at Pacific Biosciences Of California, up from -$1.9 million in the prior quarter.
• The five-year high for Other Operating Expenses was $93.9 million in Q2 2024, with the low at -$7.8 million in Q2 2022.
• Average Other Operating Expenses over 5 years is $15.5 million, with a median of $1.9 million recorded in 2022.
• The sharpest annual moves came in 2024 and 2025: Other Operating Expenses jumped 11098.01% in 2024, then slumped 360.06% in 2025.
• Over 5 years, Other Operating Expenses stood at $2.0 million in 2022, then jumped by 72.14% to $3.5 million in 2023, then jumped by 2500.94% to $91.1 million in 2024, then sank by 102.1% to -$1.9 million in 2025, then jumped by 2490.19% to $45.8 million in 2026.
• The last three Other Operating Expenses figures came in at $45.8 million (Q1 2026), -$1.9 million (Q4 2025), and -$1.6 million (Q3 2025), per Business Quant data.